Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lacey

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
International Journal of Neonatal Screening|August 18, 2020
A Comparative Effectiveness Study of Newborn Screening Methods for Four Lysosomal Storage DisordersKaren A Sanders, Dimitar K Gavrilov, Devin Oglesbee, et al.
International Journal of Neonatal Screening|October 19, 2020
Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type IDawn S Peck, Jean M Lacey, Amy L White, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2023
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomasCecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
Neuro-Oncology Advances|June 14, 2023
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomasCecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool CompoundsBrandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
Elife|November 21, 2022
Genetic therapy in a mitochondrial disease model suggests a critical role for liver dysfunction in mortalityAnkit Sabharwal, Mark D Wishman, Roberto Lopez Cervera, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma: utility for detection versus monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Neuro-Oncology Advances|March 19, 2026
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 27, 2020
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 InhibitorsBrian M Lacey, Zangwei Xu, Xiaomei Chai, et al.
Journal of Medicinal Chemistry|April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug DesignXiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
International Journal of Neonatal Screening|August 18, 2020
A Comparative Effectiveness Study of Newborn Screening Methods for Four Lysosomal Storage DisordersKaren A Sanders, Dimitar K Gavrilov, Devin Oglesbee, et al.
International Journal of Neonatal Screening|October 19, 2020
Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type IDawn S Peck, Jean M Lacey, Amy L White, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2023
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomasCecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
Neuro-Oncology Advances|June 14, 2023
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomasCecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool CompoundsBrandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
Elife|November 21, 2022
Genetic therapy in a mitochondrial disease model suggests a critical role for liver dysfunction in mortalityAnkit Sabharwal, Mark D Wishman, Roberto Lopez Cervera, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma: utility for detection versus monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Neuro-Oncology Advances|March 19, 2026
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 27, 2020
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 InhibitorsBrian M Lacey, Zangwei Xu, Xiaomei Chai, et al.
Journal of Medicinal Chemistry|April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug DesignXiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Pageof 15